Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection.
C. Orkin, K. Arastéh, M. Górgolas Hernández-Mora, V. Pokrovsky, E. Overton, P. Girard, S. Oka, S. Walmsley, Christopher Bettacchi, C. Brinson, P. Philibert, Johan Lombaard, M. S. St. Clair, H. Crauwels, S. L. Ford, P. Patel, Vasiliki Chounta, R. D'Amico, S. Vanveggel, David Dorey, A. Cutrell, Sandy Griffith, D. Margolis, P. Williams, W. Parys, Kimberly Smith, W. Spreen
New England Journal of Medicine